52 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34968163 | Magnolol attenuates the locomotor impairment, cognitive deficit, and neuroinflammation in Alzheimer's disease mice with brain insulin resistance via up-regulating miR-200c. | 2022 Jan | 1 |
2 | 33764312 | Lower threshold to NFκB activity sensitizes murine β-cells to streptozotocin. | 2021 May 6 | 2 |
3 | 34129880 | Possible involvement of agmatine in neuropharmacological actions of metformin in diabetic mice. | 2021 Sep 15 | 1 |
4 | 34279193 | Microglia NLRP3 Inflammasomes Activation Involving Diabetic Neuroinflammation in Diabetic Mice and BV2 Cells. | 2021 | 1 |
5 | 34685620 | BMP-7 Attenuates Inflammation-Induced Pyroptosis and Improves Cardiac Repair in Diabetic Cardiomyopathy. | 2021 Oct 2 | 1 |
6 | 34943114 | Umuhengerin Neuroprotective Effects in Streptozotocin-Induced Alzheimer's Disease Mouse Model via Targeting Nrf2 and NF-Kβ Signaling Cascades. | 2021 Dec 18 | 2 |
7 | 32522682 | Swimming exercise improves cognitive and behavioral disorders in male NMRI mice with sporadic Alzheimer-like disease. | 2020 Sep 1 | 2 |
8 | 32738275 | MA-[D-Leu-4]-OB3, a small molecule synthetic peptide leptin mimetic, improves episodic memory, and reduces serum levels of tumor necrosis factor-alpha and neurodegeneration in mouse models of Type 1 and Type 2 Diabetes Mellitus. | 2020 Nov | 1 |
9 | 32853650 | Inhibiting Rab27a in renal tubular epithelial cells attenuates the inflammation of diabetic kidney disease through the miR-26a-5p/CHAC1/NF-kB pathway. | 2020 Nov 15 | 1 |
10 | 30444022 | Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy. | 2019 Feb | 1 |
11 | 30054947 | Critical role of endoplasmic reticulum stress in chronic endothelial activation-induced visual deficits in tie2-tumor necrosis factor mice. | 2018 Nov | 5 |
12 | 30169672 | The effect of streptozotocin-induced hyperglycemia on N-and O-linked protein glycosylation in mouse ovary. | 2018 Nov 1 | 1 |
13 | 27108916 | Bone metabolic microarray analysis of ligature-induced periodontitis in streptozotocin-induced diabetic mice. | 2017 Apr | 2 |
14 | 27720931 | CysLT1R downregulation reverses intracerebroventricular streptozotocin-induced memory impairment via modulation of neuroinflammation in mice. | 2017 Feb 6 | 1 |
15 | 28142150 | Camel Whey Protein Protects B and T Cells from Apoptosis by Suppressing Activating Transcription Factor-3 (ATF-3)-Mediated Oxidative Stress and Enhancing Phosphorylation of AKT and IκB-α in Type I Diabetic Mice. | 2017 | 1 |
16 | 28780379 | Proinflammatory cytokine MIF plays a role in the pathogenesis of type-2 diabetes mellitus, but does not affect hepatic mitochondrial function. | 2017 Nov | 3 |
17 | 26650489 | Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production. | 2016 Apr | 1 |
18 | 27341452 | Emetine Di-HCl Attenuates Type 1 Diabetes Mellitus in Mice. | 2016 Oct | 1 |
19 | 27747335 | 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside exerted protective effects on diabetic nephropathy in mice with hyperglycemia induced by streptozotocin. | 2016 Nov 9 | 1 |
20 | 29847081 | Adipose Tissue Tumor Necrosis Factor-α. and Interleukin-6 Response to Glucocorticoid Treatment during Inflammation. | 2016 | 1 |
21 | 25160865 | Indomethacin reverses decreased hippocampal cell proliferation in streptozotocin-induced diabetic mice. | 2015 Apr | 1 |
22 | 25187369 | Arachidonate 12/15-lipoxygenase-induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy. | 2015 Feb | 1 |
23 | 25548280 | Regulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodents. | 2015 Feb 6 | 1 |
24 | 25630053 | Angelica sinensis polysaccharide regulates glucose and lipid metabolism disorder in prediabetic and streptozotocin-induced diabetic mice through the elevation of glycogen levels and reduction of inflammatory factors. | 2015 Mar | 1 |
25 | 26061548 | Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury. | 2015 Oct | 1 |
26 | 26279435 | Effect of the Total Extract of Averrhoacarambola (Oxalidaceae) Root on the Expression Levels of TLR4 and NF-κB in Streptozotocin-Induced Diabetic Mice. | 2015 | 1 |
27 | 26664261 | Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice. | 2015 | 1 |
28 | 24583009 | Hyperglycemia induces abnormal gene expression in hematopoietic stem cells and their progeny in diabetic neuropathy. | 2014 Mar 18 | 1 |
29 | 25116192 | Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy. | 2014 Nov-Dec | 1 |
30 | 25390652 | Defects in the acquisition of tumor-killing capability of CD8+ cytotoxic T cells in streptozotocin-induced diabetic mice. | 2014 | 2 |
31 | 23138030 | 25-hydroxyvitamin D3 ameliorates periodontitis by modulating the expression of inflammation-associated factors in diabetic mice. | 2013 Feb | 1 |
32 | 23339930 | Altered gene expression profiles associated with enhanced skin inflammation induced by 12-O-tetradecanoylphorbol-13-acetate in streptozotocin-diabetic mice. | 2013 Mar | 1 |
33 | 23442845 | Depressive-like behaviour induced by an intracerebroventricular injection of streptozotocin in mice: the protective effect of fluoxetine, antitumour necrosis factor-α and thalidomide therapies. | 2013 Apr | 2 |
34 | 24076200 | Renoprotective effect of ramulus mori polysaccharides on renal injury in STZ-diabetic mice. | 2013 Nov | 2 |
35 | 21458563 | Peroxisome proliferator-activated receptor δ downregulates the expression of the receptor for advanced glycation end products and pro-inflammatory cytokines in the kidney of streptozotocin-induced diabetic mice. | 2011 May 18 | 1 |
36 | 21498084 | Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. | 2011 Sep | 1 |
37 | 20020468 | Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts. | 2010 Mar | 1 |
38 | 20185810 | Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes. | 2010 May | 1 |
39 | 22419922 | Efficacy of Setarud (IMOD™), a novel electromagnetically-treated multi-herbal compound, in mouse immunogenic type-1 diabetes. | 2010 Oct | 1 |
40 | 19755528 | Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice. | 2009 Oct | 2 |
41 | 16054232 | Prolactin regulation of the expression of TNF-alpha, IFN-gamma and IL-10 by splenocytes in murine multiple low dose streptozotocin diabetes. | 2006 Jan 15 | 2 |
42 | 16260089 | Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha. | 2006 Feb 13 | 1 |
43 | 15790737 | Inflammation is more persistent in type 1 diabetic mice. | 2005 Apr | 1 |
44 | 16148116 | Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin. | 2005 Sep 15 | 1 |
45 | 14647895 | TNF-alpha acts to prevent occurrence of malformed fetuses in diabetic mice. | 2004 Jan | 1 |
46 | 15205889 | Popliteal lymph node responses to acetone and ethanol differ from those induced by streptozotocin. | 2004 Nov | 1 |
47 | 14555286 | Cytokine release by murine spleen cells following multiple low dose streptozotocin-induced diabetes and treatment with a TNFalpha transcriptional inhibitor. | 2003 Nov | 1 |
48 | 11999343 | Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. | 2002 Mar | 2 |
49 | 11437492 | A transcriptional inhibitor of TNF-alpha prevents diabetes induced by multiple low-dose streptozotocin injections in mice. | 2001 Jun | 3 |
50 | 11506081 | Expression of tumor necrosis factor-alpha in the pregnant uterus of diabetic mice: effect of maternal immunopotentiation. | 2001 Aug | 1 |